AliveCor launches mobile app to monitor heart rhythm


AliveCor has launched a mobile heart health service, offering expert review of electrocardiograms recorded through their smartphone app. Patients can share these expert reviews and their electrocardiograms with their physicians. Physicians in turn can manage their patients through, using their PC or tablet.

According to the company, expert review of electrocardiograms is available through AliveInsights within the AliveECG app. Patients and their physicians can choose to receive on their smartphone a technical review performed by a US-based cardiac technician, or a more in-depth clinical review from a US board-certified cardiologist, for a fee. This resource is available 24 hours a day, seven days a week.

“AliveCor’s new integrated mobile health service offers unprecedented benefits to both patients and physicians,” said Ronald P Karlsberg, Cedars Sinai Heart Institute, Cardiovascular Medical Group of Southern California, and clinical professor of Medicine at the David Geffen School of Medicine UCLA, USA. “This eHealth service makes it easier for physicians to manage the heart condition of their patients, wherever they and their patients are. Just as the introduction of thermometers and blood pressure cuffs in the past helped patients to monitor their health, now the ability to record one’s own electrocardiogram and get an interpretation almost instantly empowers the 21st century patient to take charge of their heart health.”

“This is a major step in achieving our vision for mobile health”, said Euan Thomson, CEO and president of AliveCor.

The AliveCor Heart Monitor is an FDA-cleared mobile electrocardiograms recorder that supports both iPhone and Android compatible smartphones. It records, displays, annotates, stores, and transfers single-channel electrocardiogram rhythms wirelessly, using the free AliveECG app. With secure storage in the Cloud, patients can access their data confidentially and can grant access to their physician. The Heart Monitor is available for purchase in the USA by medical professionals and patients with prescriptions.